Publications

V. Perkovic and A. Cass, “Glomerular filtration rate and the risk of stroke”, BMJ (Clinical Research Ed.)BMJ (Clinical Research Ed.), vol. 341, p. c4390, 2010.

M. P. Gallagher, M. Jardine, A. MacLeod, J. Craig, P. Snelling, and A. Cass, “Implementing renal anaemia guidelines: using a standardised treatment algorithm at a unit level”, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 80., Perth, Australia, September, 2010.

M. Jun, H. J. Heerspink, T. Ninomiya, M. P. Gallagher, R. Bellomo, J. Myburgh, S. R. Finfer, P. M. Palevsky, J. A. Kellum, V. Perkovic, and A. Cass, “Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis”, Clinical Journal of the American Society of Nephrology, vol. 5, pp. 956-63, 2010.

S. Badve, E. Beller, A. Cass, D. Francis, C. Hawley, I. MacDougall, V. Perkovic, and D. Johnson, “Interventions for erythropoietin-resistant anaemia in dialysis patients: a systematic review”, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 80., Perth, Australia, September, 2010.

S. V. Badve, E. Beller, A. Cass, D. P. Francis, C. Hawley, I. C. MacDougall, V. Perkovic, and D. W. Johnson, “ Interventions for erythropoietin-resistant anaemia in dialysis patients (Protocol). ”, Cochrane Database of Systematic Reviews Cochrane Database of Systematic Reviews, p. CD006861, 2010.

A. Cass, “(Invited Speaker) Domestic and international research collaborations in chronic kidney disease. ”, in World Congress of Internal Medicine, Melbourne, Australia, March , 2010.

H. Liu, D. Peiris, N. Hayman, B. Fewquandie, T. Senior, A. Brown, and A. Cass, “Is there a safe and high quality care for Aboriginal and Torres Strait Islander peoples: A perspective from the Kanyini Vascular Collaboration (Chapter 4)”, Australian Commission for Safety and Quality in Health Care, Sydney, Australia, 2010.

A. Cass, “(Keynote Speaker) Diabetic kidney disease: Epidemiology and Prevention. ”, in Endocrine Society of Australia Annual Scientific Meeting, Wollongong, Australia, May, 2010.

A. Cass, “(Keynote speaker) Economics of home-based dialysis therapies”, in 3rd Australian and New Zealand Home Dialysis Therapies Workshop, Brisbane, February, 2010.

A. Cass, “(Keynote Speaker) The Epidemic of End-Stage Kidney Disease in the Asia-Pacific Region: We must act now ”, in International Dialysis Forum, Taiwan Society of Nephrology and Institute for Biotechnology and Medicine Industry. , Taipei, Taiwan, July, 2010.

C. Foote, P. Clayton, M. Jardine, A. Cass, and P. Snelling, “Late referral in the eGFR era”, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 86., Perth, Australia, September, 2010.

M. P. Gallagher, P. J. Kelly, M. Jardine, V. Perkovic, A. Cass, J. C. Craig, J. Eris, and A. C. Webster, “Long-term cancer risk of immunosuppressive regimens after kidney transplantation”, J Am Soc NephrolJournal of the American Society of Nephrology, vol. 21, pp. 852-8, 2010.

M. Razavian, E. Heeley, V. Perkovic, S. Zoungas, A. Weekes, A. Patel, C. Anderson, J. Chalmers, AC, and A. Cass, “Management of chronic kidney disease in Australian general practice (the AusHEART Study)”, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 71., Perth, Australia, 2010.

M. Jun, M. Jardine, N. Gray, R. Masterson, P. Kerr, J. Agar, C. van Eps, C. Hawley, A. Cass, M. P. Gallagher, and V. Perkovic, “Outcomes associated with extended hours haemodialysis (EHHD)”, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 38, Perth, Australia, September, 2010.

M. Jun, M. Jardine, N. Gray, R. Masterson, P. Kerr, J. Agar, C. Hawley, C. van Eps, A. Cass, M. P. Gallagher, and V. Perkovic, “Outcomes in home extended hours haemodialysis (HEHHD). ”, in Third Australia and New Zealand Home Therapies Workshop, Brisbane, Australia, February, 2010.

R. L. Morton, J. Devitt, K. Howard, K. Anderson, P. Snelling, and A. Cass, “Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews”, Am J Kidney DisAmerican Journal of Kidney Diseases, vol. 55, pp. 431-40, 2010.

A. Cass, “(Plenary Speaker) Economic impact of the future of chronic kidney disease and transplantation in Australia. ”, in Roche Nephrology Transplant Symposium, Sydney, Australia, August, 2010.

S. Chadban, M. Howell, S. Twigg, M. Thomas, G. Jerums, A. Cass, D. Campbell, K. Nicholls, A. Tong, G. Mangos, A. Stack, R. J. MacIsaac, S. Girgis, R. Colagiuri, S. Colagiuri, and J. Craig, “Prevention and management of chronic kidney disease in type 2 diabetes”, NephrologyNephrology, vol. 15, pp. S162-S194, 2010.

H. Liu, A. Patel, A. Brown, S. Eades, N. Hayman, S. Jan, I. Ring, G. Stewart, A. Tonkin, T. Weeramanthri, V. Wade, A. Rodgers, T. Usherwood, B. Neal, D. Peiris, H. Burke, C. Reid, A. Cass, and K. G. A. P. Study Team, “Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk”, BMC Public Health, vol. 10, p. 458, 2010.

D. Peiris, M. Mohsin, A. J. Jenkins, C. Hughes, and A. Cass, “Robust data to close the gap: current vascular and maternal/newborn indicators as measures of progress in Aboriginal health in New South Wales”, Australian and New Zealand Journal of Public HealthAustralian and New Zealand Journal of Public Health, vol. 34, pp. 563-71, 2010.

T. H. Mathew, O. Corso, M. Ludlow, A. Boyle, A. Cass, S. J. Chadban, B. Joyner, M. Shephard, and T. Usherwood, “Screening for chronic kidney disease in Australia: a pilot study in the community and workplace”, Kidney Int SupplKidney International. Supplement, pp. S9-16, 2010.

A. Cass, “Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease”, American Heart Journal, vol. 160, pp. 785-794 e10, 2010.

L. J. Maple-Brown, P. D. Lawton, J. T. Hughes, S. K. Sharma, G. R. Jones, A. G. Ellis, W. Hoy, A. Cass, R. J. MacIsaac, A. K. Sinha, M. A. Thomas, L. S. Piers, L. C. Ward, K. Drabsch, S. Panagiotopoulos, R. McDermott, K. Warr, S. Cherian, A. Brown, G. Jerums, and K. O'Dea, “Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR study”, BMC Public HealthBMC Public Health, vol. 10, p. 80, 2010.

C. Foote, S. Tranter, E. Jossland, M. Jardine, A. Cass, F. Brennan, and M. Brown, “Symptom burden in a palliative nephrology clinic”, 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Nephrology 2010; 15 (S4): 75., Perth, Australia, September, 2010.

A. Cass, S. Chadban, M. P. Gallagher, K. Howard, A. Jones, S. McDonald, P. Snelling, and S. L. White, “The economic impact of end-stage kidney disease in Australia: projections to 2020. ”, Kidney Health Australia. Melbourne, Australia, 2010.